Non–Small Cell Lung Cancer, Version 1.2015

作者：David S. Ettinger, Douglas E. Wood, Wallace A. Akerley, Lyudmila A. Bazhenova, Hossein Borghaei, David Ross Camidge, Richard T. Cheney, Lucian R. Chirieac, Thomas Anthony D’Amico, Todd L. Demmy, Thomas J. Dilling, Ramaswamy Govindan, Frederic W. Grannis, Leora Horn, Thierry Marie Jahan, Ritsuko U Komaki, Mark G. Kris, Lee M. Krug, Rudy P. Lackner, Michael D. Lanuti, Rogério Lilenbaum, Jules Lin, Billy Wiseman Loo Jr., Renato G Martins, Gregory A. Otterson, Jyoti D. Patel, Katherine M.W. Pisters, Karen L. Reckamp, Gregory J. Riely, ERIC M. ROHREN, Steven E. Schild, Theresa A. Shapiro, Steven Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes · 发表于：Journal of the National Comprehensive Cancer Network · 年份：2014 · DOI：10.6004/jnccn.2014.0176 · 被引用次数：221 · 研究领域：Lung Cancer Diagnosis and Treatment、Advanced Radiotherapy Techniques、Lung Cancer Treatments and Mutations

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) focuses on the principles of radiation therapy (RT), which include the following: (1) general principles for early-stage, locally advanced, and advanced/metastatic NSCLC; (2) target volumes, prescription doses, and normal tissue dose constraints for early-stage, locally advanced, and advanced/palliative RT; and (3) RT simulation, planning, and delivery. Treatment recommendations should be made by a multidisciplinary team, including board-certified radiation oncologists who perform lung cancer RT as a prominent part of their practice.